WASHINGTON, Sept 10 ― Top US health officials believe that Pfizer Inc's Covid-19 vaccine could be authorised for children aged 5-11 years old by the end of October, two sources familiar with the situation said yesterday.
They anticipate the FDA could make a decision on whether the shot is safe and effective in younger children within three weeks of the EUA submission. Top US infectious disease expert Dr. Anthony Fauci outlined the timetable during an online town hall meeting attended by thousands of staff at the National Institutes of Health yesterday, according to one of the sources. A second source familiar with the situation said that the FDA anticipated a similar timeline for Pfizer.
Fauci said that Moderna Inc will likely take about three weeks longer than Pfizer to collect and analyse its data on children age 5-11, according to the source. He estimated that a decision on the Moderna shot could come around November, according to the source. The second source said Fauci's timeline for Moderna appeared “optimistic.”Pfizer has previously said that it would have data on children age 5-11 ready in September and planned to submit for an EUA shortly after.
Generally, vaccines 💉 were NEVER approved because in the animal trials, all of them either died or developed serious auto-immune disorders. Suddenly it is safe enough to experiment it on humans for a virus that has a 99%+ survival rate while the safer, and much more effective
You know this, don’t you? So why do you still perpetuate this FLAWED narrative that vaccines cure? It doesn’t!
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA declines emergency use approval for Humanigen's Covid-19 drug | Malay MailWASHINGTON, Sept 9 ― The US Food and Drug Administration declined Humanigen Inc's request for emergency use authorisation (EUA) of its lenzilumab drug to treat newly hospitalised Covid-19 patients, the company said today. “In its letter, FDA stated that it was unable to conclude that the known...
Source: malaymail - 🏆 1. / 86 Read more »
Covid-19: US to double fines for travellers not wearing masks | Malay MailWASHINGTON, Sept 10 ― The Transportation Security Administration (TSA) is doubling fines for first-time offenders who fail to wear masks, effective today, and said repeat offenders could face fines as high as US$3,000 (RM12,443). The White House said President Joe Biden was directing the higher...
Source: malaymail - 🏆 1. / 86 Read more »
US airlines warn of drag from latest Covid-19 wave | New Straits TimesNSTworld Several leading US airlines cut their forecasts for the third quarter, citing lower bookings and increased cancellations due to the latest wave of Covid19 infections. coronavirus aviation
Source: NST_Online - 🏆 17. / 53 Read more »
Biden slams 'minority' preventing US from overcoming Covid | New Straits TimesNSTworld President JoeBiden blamed vaccine hesitant Americans for preventing the United States from overcoming the Covid19 pandemic. coronavirus
Source: NST_Online - 🏆 17. / 53 Read more »
UK airline easyJet rejects bid offer, to raise US$1.7b | Malay MailLONDON, Sept 9 — British airline easyJet said it had rejected a takeover offer on Thursday and would raise US$1.7 billion (RM7 billion) from shareholders to fund its pandemic recovery and expand operations. The company said the all-share approach fundamentally undervalued the business. It said...
Source: malaymail - 🏆 1. / 86 Read more »
EasyJet rejects Wizz bid and raises US$1.7b to go it alone | Malay MailLONDON, Sept 9 — EasyJet has rejected a takeover approach from Wizz Air that would have created a low-cost airline to rival Ryanair, opting instead to raise US$1.7 billion from shareholders and go it alone in an industry battling to recover from the pandemic. EasyJet declined to name its suitor,...
Source: malaymail - 🏆 1. / 86 Read more »